Cargando…

Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside

BACKGROUND: Immune checkpoint inhibitor (ICI) therapy is first-line treatment for many advanced non-small cell lung cancer (aNSCLC) patients. Predicting response could help guide selection of intensified or alternative anti-cancer regimens. We hypothesized that radiomics and laboratory variables pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Montoya, Chris, Spieler, Benjamin, Welford, Scott M., Kwon, Deukwoo, Pra, Alan Dal, Lopes, Gilberto, Mihaylov, Ivaylo B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686412/
https://www.ncbi.nlm.nih.gov/pubmed/38033493
http://dx.doi.org/10.3389/fonc.2023.1225720

Ejemplares similares